Summary
This study describes the effects of nicotinamide therapy on B-cell function in Type 1 (insulin-dependent) diabetes. C-peptide secretion was studied in 20 patients newly diagnosed with Type 1 diabetes at basal state and also after an i.v. glucagon stimulus. Patients were randomly allocated according to a single-blind schedule, to one of the following treatments over a 45-day period: Group 1: 10 patients, nicotinamide 1 g/day; Group 2: 10 patients, placebo. The C-peptide secretion tests were performed before treatment and on days 15, 45, 180, 365 of the follow-up. The clinical and metabolic data were similar in the two groups of patients. Basal and stimulated C-peptide levels increased by 45 days in both groups, but the increase in stimulated C-peptide response was greater in the nicotinamide group (p<0.01). However, the B-cell function decreased after the period of nicotinamide administration. No difference in the number of clinical remissions or insulin requirement and HbA1 between the groups was observed. These data suggest that treatment of Type 1 diabetes with nicotinamide at diagnosis is associated with a moderate increase of C-peptide secretion recovery.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Botazzo GF, Pujol-Borrell R, Gale E (1986) Autoimmunity and diabetes: progress, consolidation and controversy. Alberti KGMM, Krall LP (eds) The diabetes annual 2. Elsevier, London, pp 13–29
Stiller CR, Dupre J, Gent MR, Jenner PA, Keown PA, Laupacis A, Martell R, Rodger NW, Graffenried B, Wolfe MJ (1984) Effects of cyclosporine immunosuppression in insulin-dependent diabetes mellitus of recent onset. Science 223: 1362–1367
Elliot RB, Crossley JR, Berryman CC, James AG (1981) Partial preservation of pancreatic B-Cell function in children with diabetes. Lancet II: 1–4
Ludvigsson J, Heding L, Lieden G, Marner B, Lernmark Å (1983) Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children. Br Med J 286: 176–178
Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S (1982) Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis Diabetes 31: 749–753
Uchigata Y, Yamamoto H, Nagai H, Okamoto H (1983) Effect of poly-(ADP-ribose) synthetase inhibitor administration to rats before and after injection of alloxan and streptozotocin on islet proinsulin synthesis. Diabetes 32: 316–318
Yonemura Y, Takashima T, Miwa K, Miyazadi I, Yamamoto H, Okamoto H (1984) Amelioration of diabetes mellitus in partially depancreatized rats by poly-ADP-ribose synthetase inhibitors: evidence of islet B-cell regeneration. Diabetes 33: 401–404
Vague Ph, Vialettes B, Lassman-Vague V, Vallo JJ (1987) Nicotinamide may extend remission phase in insulin dependent diabetes. Lancet I: 619
Tarn AC, Smith CP, Spencer KM, Botazzo GF, Gale EAM (1987) Type 1 (insulin dependent) diabetes: a disease of slow clinical onset? Br Med J 294: 342–345
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Kuzuya T, Matsuda A, Saito T, Yoshia S (1976) Human C-peptide immuno-reactivity (CPR) in blood and urine evaluation of radioimmunoassay method and its clinical applications. Diabetologia 12: 511–518
Bonifacio E, Dawkins RL, Lernmark Å (1987) Immunology and diabetes workshop: report of the second international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 30: 273
Passey RB, Gillum RL, Fuller JB, Urry FM, Giles ML (1977) Evaluation and comparison of 10 glucose methods and the reference method recommended in the product class standard. Clin Chem 23: 131–135
Gomis R, Figuerola D, Micalo T, Millan M, Peig M (1981) Hemoglobina glucosilada como indice de control de la diabetes mellitus. Med Clin (Barcelona) 76: 251–254
Yamamoto H, Uchigata Y, Okamoto H (1981) DNA strand breaks in pancreatic islet by “in vivo” administration of alloxan or streptozotocin. Biochem Biophys Res Commun 103: 1014–1020
Yamamoto H, Uchigata Y, Okamoto H (1981) Streptozotocin and alloxan induce DNA strand breaks and poly-(ADP-ribose) synthetase in pancreatic islet. Nature 294: 284–286
Yamamoto H, Okamoto H (1980) Protection by picolinamide, a novel inhibitor of poly-(ADP-ribose) synthetase, against both streptozotocin-induced depression of proinsulin synthesis and reduction of NAD content in pancreatic islets. Biochem Biophys Res Commun 95: 474–481
Okamoto H (1981) Regulation of proinsulin synthesis in pancreatic islets and a new aspect to insulin-dependent diabetes. Mol Cell Biochem 37: 43–61
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mendola, G., Casamitjana, R. & Gomis, R. Effect of nicotinamide therapy upon B-cell function in newly diagnosed Type 1 (insulin-dependent) diabetic patients. Diabetologia 32, 160–162 (1989). https://doi.org/10.1007/BF00265087
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00265087